Company Filing History:
Years Active: 2009
Title: Tracey Doucette: Innovator in Epilepsy Research
Introduction
Tracey Doucette, an accomplished inventor based in Stanhope, CA, is recognized for her significant contributions to the field of neuroscience. With her innovative approach to understanding temporal lobe epilepsy and seizure-related disorders, she has made strides in developing methods that could enhance research in this critical area.
Latest Patents
Tracey Doucette holds a patent titled "Developmental animal model of temporal lobe epilepsy." This innovative patent discloses a method for inducing permanent neurological changes in rodents, specifically rats, through daily administration of low doses of a kainate receptor agonist during the second postnatal week. Following this treatment, the animals exhibit reproducible seizure-like symptoms when exposed to mild to moderate stressors. This model not only provides insights into temporal lobe epilepsy but also serves as an excellent non-human system for evaluating potential anti-epileptic compounds and pharmaceutical preparations.
Career Highlights
Currently, Tracey is affiliated with H:S Rigshospitalet, where her work intersects with various aspects of medical research and innovation. Her dedication to understanding and developing treatments for epilepsy is evident through her patent, which facilitates vital research opportunities for future therapies.
Collaborations
In her journey, Tracey has collaborated with notable colleagues, including Henriette Husum Bak-Jensen and Melissa Perry. These partnerships reflect a commitment to advancing scientific knowledge and enhancing the methodologies used in epilepsy research.
Conclusion
Tracey Doucette's innovative work and her patented developmental animal model of temporal lobe epilepsy mark significant progress in the field of neuroscience. Her contributions will likely pave the way for new therapeutic approaches, aiming to improve the lives of those affected by epilepsy and seizure-related disorders.